Commerzbank Aktiengesellschaft’s Novavax NVAX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-553	Closed	-$14K	–	844
2017 Q1	$14K	Sell	553 -3,851	-87%	-$106K	﹤0.01%	921
2016 Q4	$111K	Sell	4,404 -13,216	-75%	-$385K	﹤0.01%	942
2016 Q3	$733K	Buy	17,620 +16,474	+1,438%	+$2.13M	0.01%	481
2016 Q2	$167	Buy	1,146 +321	+39%	+$36.8K	﹤0.01%	942
2016 Q1	$85K	Sell	825 -390	-32%	-$41.8K	﹤0.01%	991
2015 Q4	$204K	Buy	+1,215	New	+$187K	﹤0.01%	1066
2015 Q2	–	Sell	-774	Closed	-$128K	–	1209
2015 Q1	$128K	Buy	+774	New	+$126K	﹤0.01%	1112
2014 Q2	–	Sell	-1,535	Closed	-$139K	–	1217
2014 Q1	$139K	Buy	+1,535	New	+$171K	﹤0.01%	1162
2013 Q3	–	Sell	-1,780	Closed	-$73K	–	1380
2013 Q2	$73K	Buy	+1,780	New	+$77.1K	﹤0.01%	1421

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commerzbank Aktiengesellschaft's NVAX Position: Q2 2017 in Review

Commerzbank Aktiengesellschaft sold out of Novavax (NVAX) in Q2 2017, closing a stake of 553 shares — an estimated $14K sold.

Commerzbank Aktiengesellschaft first reported a position in NVAX in Q2 2013 and held it in 9 quarters. The position peaked at $733K in Q3 2016. 126 funds tracked by Wall St. Rank hold NVAX as of Q2 2017.

Commerzbank Aktiengesellschaft reported no remaining Novavax position as of Q2 2017 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 553 Novavax shares in Q2 2017, an estimated $14K.
Commerzbank Aktiengesellschaft first reported a position in Novavax in Q2 2013 and held it in 9 quarters.
Commerzbank Aktiengesellschaft's Novavax position peaked at $733K in Q3 2016.
126 funds tracked by Wall St. Rank held Novavax as of Q2 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2017, filed 9 Aug 2017.